About | Free Trial

Last Update

2016-04-14T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Elaine Mardis?

Dr. Elaine Mardis R.

Co-director

Genome Sequencing Center

Direct Phone: (314) ***-****       

Email: e***@***.edu

Genome Sequencing Center

4444 Forest Park Boulevard

St. Louis, Missouri 63108

United States

Company Description

The Genome Partnership has been proudly organizing The Advances in Genome Biology and Technology (AGBT) General Meeting for the past 17 years. In September of 2016 we are launching our inaugural AGBT Precision Health Meeting. The Genome Partnership is a n... more

Find other employees at this company (37)

Background Information

Employment History

Associate Editor of Molecular Cancer Research
Disease Models

Editor-in-Chief
Molecular Case Studies

Affiliations

Advisory Board Member
DNA Sequencing Inc

Advisory Board Member
DNA Sequencing Inc

Chair of the Basic and Translational Sciences Committee
American College of Surgeons

Scientific Advisory Board Member
Ingenuity Systems Inc

Board Member
Applied Biosystems Inc.

Member
American Society of Human Genetics

Board Member
American Association for Cancer Research Inc

Education

B.S.
Zoology
Oklahoma University

B.S. degree
zoology
University of Oklahoma

Ph.D.

National Human Genome Research Institute

Ph.D.

The Genome Institute of Washington University

Ph.D.

Washington University

Ph.D.

Washington University School of Medicine

Ph.D.
Biochemistry and Chemistry
University of Oklahoma

Ph.D.
Chemistry and Biochemistry
Oklahoma University

PhD

Scripps Translational Science Institute

PhD

The Genome Institute at Washington University

Web References (197 Total References)


Elaine Mardis, Ph.D., ...

www.agbt.org [cached]

Elaine Mardis, Ph.D., graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.

In 1993, Dr. Mardis joined the faculty at Washington University School of Medicine. Recruited for her expertise in DNA sequencing and automation technology, she served as Director of Technology Development at the (then) Washington University Genome Sequencing Center, helping create methods and automation pipelines for sequencing the Human Genome. She has served as Co-director of the McDonnell Genome Institute since 2002. In 2014, Dr. Mardis was named the Robert E. and Louise F. Dunn Distinguished Professor of Medicine.
...
Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She co-led the teams that first used next-generation sequencing to characterize the whole genome of an AML patient (Nature 2008), first sequenced and compared a primary tumor to its metastasis and xenograft, and first reported whole genome sequencing of samples from a breast cancer clinical trial. Beyond cancer genomics discoveries, Dr. Mardis is leading efforts to facilitate the translation of basic science discoveries about human genetic diseases into the clinical setting, especially focused on the use of next-generation sequencing. Her translational research efforts aim to devise NGS-based diagnostics, decision-support tools and databases, and the use of genomics to design personalized cancer vaccines.
Dr. Mardis was elected to the AACR Board of Directors in 2015. She serves as an associate editor of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology, and acts as a reviewer for Nature, the New England Journal, Cell and Science. She is the Editor-in-Chief of Molecular Case Studies. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics, and is a member of the Supervisory Board of Qiagen N.V. Dr. Mardis received the 2010 Scripps Translational Research award for her work on cancer genomics, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences in 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories of 2013. In 2014 and 2015, she was one of the most highly cited researchers in the world, according to Thompson-Reuters. She will receive the Morton K. Schwartz award from the American Association of Clinical Chemistry for Significant Contributions in Cancer Research Diagnostics in 2016.


This is particularly important because ...

www.rapidscience.org [cached]

This is particularly important because journals are often hesitant to publish results from a single individual, notes Elaine Mardis, co-director of the Genome Institute at Washington University in St Louis, Missouri. Mardis has advocated for establishing an online journal that would permit quick publication of n-of-1 results, as a way to rapidly release information and give researchers incentive to study patients who seem to be outliers."


Elaine Mardis, Ph.D., ...

www.personalizedmedicinepartnerships.com [cached]

Elaine Mardis, Ph.D., Professor and Co-Director of The Genome Institute at Washington University School of Medicine, introduced exciting work in the design of patient-unique cancer vaccines. Such immunotherapies can even be combined with existing cancer drugs, e.g., checkpoint inhibitors, in priming strategies that "wake-up" the immune system prior to vaccination. She cited pediatric glioma, especially the recurrent setting, as an area of notable success to date.


"The number of mutations identified per ...

www.quaddrix.com [cached]

"The number of mutations identified per megabase of DNA was pretty astounding," said Elaine Mardis, director of technology development at The Genome Institute at Washington University in St. Louis, who was not involved in the work.


"The number of mutations identified per ...

quaddrix.com [cached]

"The number of mutations identified per megabase of DNA was pretty astounding," said Elaine Mardis, director of technology development at The Genome Institute at Washington University in St. Louis, who was not involved in the work.

Similar Profiles

Other People with this Name

Other people with the name Mardis

Elaine Mardis
The EMBO Meeting

Jane Mardis
LAH Real Estate Inc

Julie Mardis
Pittsboro United Methodist Church

Bruce Mardis
BHH Affiliates LLC

James Mardis
Indiana Association for Floodplain and Stormwater Management Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory